A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events

Introduction: Antiretroviral therapy (ART) is a lifelong commitment for human immunodeficiency virus infection (HIV)-positive patients. The patients may develop early adverse drug reactions (ADRs) during the first 3 months of treatment, especially when they have advanced HIV disease with low CD4 cou...

Full description

Bibliographic Details
Main Authors: Vikas Kumar, Jatinder Singh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Global Infectious Diseases
Subjects:
Online Access:http://www.jgid.org/article.asp?issn=0974-777X;year=2019;volume=11;issue=2;spage=73;epage=79;aulast=Kumar
_version_ 1819079614008393728
author Vikas Kumar
Jatinder Singh
author_facet Vikas Kumar
Jatinder Singh
author_sort Vikas Kumar
collection DOAJ
description Introduction: Antiretroviral therapy (ART) is a lifelong commitment for human immunodeficiency virus infection (HIV)-positive patients. The patients may develop early adverse drug reactions (ADRs) during the first 3 months of treatment, especially when they have advanced HIV disease with low CD4 counts. Materials and Methods: The present study was a prospective observational study that took place from January 2017 to July 2017 at ART center, Government Medical College, Amritsar, Punjab, India. The primary objective of the study was to evaluate ADRs to ART and immunological status in HIV-positive patients. The patients received ART regimens as per the National AIDS Control Organization guidelines. The sample included both ART-naïve and ART-experienced HIV-positive patients. The causality of reported ADRs assessed according to the World Health Organization guidelines. The study was conducted after taking approval from the Institutional Ethics Committee, Government Medical College, Amritsar, and informed consent from the patients. Data were analyzed statistically using Chi-square test, and P < 0.05 was considered statistically significant. Results: Out of total 350 patients screened during study period, 84 patients reported with confirmed ADRs. The most widely used treatment regimen was tenofovir + lamivudine + efavirenz (59.52%). Central nervous system (19.05%)-, renal (14.29%)-, and immune reconstitution inflammatory syndrome (14.29%)-related ADRs were mostly reported. The causality assessment revealed insignificant P value (Chi-square = 8.656 and P = 0.07), with 19.05% probable and 80.95% possible ADRs. Conclusions: The CD4 count <200/μl at the initiation of ART and treatment duration <1 year proved to be predictors for ADRs. Early initiation of ART in HIV-positive patients can improve immunological status and decrease in the incidence of ADRs.
first_indexed 2024-12-21T19:31:47Z
format Article
id doaj.art-1513fc6ca1ca4fb4b6405b6bf8954d78
institution Directory Open Access Journal
issn 0974-777X
language English
last_indexed 2024-12-21T19:31:47Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Global Infectious Diseases
spelling doaj.art-1513fc6ca1ca4fb4b6405b6bf8954d782022-12-21T18:52:42ZengWolters Kluwer Medknow PublicationsJournal of Global Infectious Diseases0974-777X2019-01-01112737910.4103/jgid.jgid_160_18A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse eventsVikas KumarJatinder SinghIntroduction: Antiretroviral therapy (ART) is a lifelong commitment for human immunodeficiency virus infection (HIV)-positive patients. The patients may develop early adverse drug reactions (ADRs) during the first 3 months of treatment, especially when they have advanced HIV disease with low CD4 counts. Materials and Methods: The present study was a prospective observational study that took place from January 2017 to July 2017 at ART center, Government Medical College, Amritsar, Punjab, India. The primary objective of the study was to evaluate ADRs to ART and immunological status in HIV-positive patients. The patients received ART regimens as per the National AIDS Control Organization guidelines. The sample included both ART-naïve and ART-experienced HIV-positive patients. The causality of reported ADRs assessed according to the World Health Organization guidelines. The study was conducted after taking approval from the Institutional Ethics Committee, Government Medical College, Amritsar, and informed consent from the patients. Data were analyzed statistically using Chi-square test, and P < 0.05 was considered statistically significant. Results: Out of total 350 patients screened during study period, 84 patients reported with confirmed ADRs. The most widely used treatment regimen was tenofovir + lamivudine + efavirenz (59.52%). Central nervous system (19.05%)-, renal (14.29%)-, and immune reconstitution inflammatory syndrome (14.29%)-related ADRs were mostly reported. The causality assessment revealed insignificant P value (Chi-square = 8.656 and P = 0.07), with 19.05% probable and 80.95% possible ADRs. Conclusions: The CD4 count <200/μl at the initiation of ART and treatment duration <1 year proved to be predictors for ADRs. Early initiation of ART in HIV-positive patients can improve immunological status and decrease in the incidence of ADRs.http://www.jgid.org/article.asp?issn=0974-777X;year=2019;volume=11;issue=2;spage=73;epage=79;aulast=KumarAdverse drug reactionsantiretroviral therapyCD4 countshuman immunodeficiency virusWorld Health Organization causality assessment
spellingShingle Vikas Kumar
Jatinder Singh
A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
Journal of Global Infectious Diseases
Adverse drug reactions
antiretroviral therapy
CD4 counts
human immunodeficiency virus
World Health Organization causality assessment
title A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
title_full A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
title_fullStr A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
title_full_unstemmed A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
title_short A prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus-positive adults on immunological status and adverse events
title_sort prospective study on impact of early initiation of antiretroviral therapy in human immunodeficiency virus positive adults on immunological status and adverse events
topic Adverse drug reactions
antiretroviral therapy
CD4 counts
human immunodeficiency virus
World Health Organization causality assessment
url http://www.jgid.org/article.asp?issn=0974-777X;year=2019;volume=11;issue=2;spage=73;epage=79;aulast=Kumar
work_keys_str_mv AT vikaskumar aprospectivestudyonimpactofearlyinitiationofantiretroviraltherapyinhumanimmunodeficiencyviruspositiveadultsonimmunologicalstatusandadverseevents
AT jatindersingh aprospectivestudyonimpactofearlyinitiationofantiretroviraltherapyinhumanimmunodeficiencyviruspositiveadultsonimmunologicalstatusandadverseevents
AT vikaskumar prospectivestudyonimpactofearlyinitiationofantiretroviraltherapyinhumanimmunodeficiencyviruspositiveadultsonimmunologicalstatusandadverseevents
AT jatindersingh prospectivestudyonimpactofearlyinitiationofantiretroviraltherapyinhumanimmunodeficiencyviruspositiveadultsonimmunologicalstatusandadverseevents